Combined synopsis and solicitation, total small business set-aside
Synthesis of Drugs/Chemical Substances
15DDHQ26P00000584
Drug Enforcement Administration, Office of Diversion Control. Testing Laboratories and Services.
Response deadline
June 5, 2026 at 10:00 AM EDT
Closed 103 days ago. Posted May 28, 2026, first published May 27, 2026. Scheduled to archive June 20, 2026.
Description
As published on SAM.gov.
1. This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; quotes are being requested and a written solicitation will not be issued.
2. This notice incorporates provisions and clauses in effect through Drug Enforcement Administration (DEA) Clause Matrix updated through FAC 2024-02. The complete text of any of the clauses and provisions may be accessed in full text at www.acquisition.gov.
3. This Combined Synopsis/Solicitation is 100% Small Business Set-Aside. The associated North American Industrial Classification System (NAICS) code for this procurement is 541380 - Testing Laboratories and Services with a business size standard of $41.5 Million.
AMENDMENT 01 - 5/28/2026 Revises the description on page 1; #4;
From: DEA has a requirement for a contractor to provide DNA Testing.
To:
DEA has a requirement for a contractor to provide synthesis of drugs/chemical substances. All other terms and conditions remain the same and in full force and effect. See Attachment for more details.
Publications
Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.
Points of contact
- Kenny DouangmalaKenny.J.Douangmala@dea.gov